Pelham R W, Munsat T L
Brain Res. 1979 Aug 10;171(3):473-80. doi: 10.1016/0006-8993(79)91051-5.
[3H]Quinuclidinyl benzilate (QNB) binds to specific muscarinic receptors of rat striatum, in vivo. The binding is saturable and displaceable by muscarinic drugs. Clozapine and thioridazine are unique antipsychotic agents with low liability for extrapyramidal side-effects, and both displaced ONB, while several other neuroleptics did not. In addition to this apparent direct competition for cholinergic receptors, morphine and amphetamine increased ONB binding by indirect influences on muscarinic receptors. In vivo QNB binding not only confirms in vitro findings, but it also detects indirect, probably transsynaptic, alterations of muscarinic cholinergic receptor dynamics.
[3H] 奎宁环基苯甲酸酯(QNB)在体内可与大鼠纹状体的特定毒蕈碱受体结合。这种结合具有饱和性,且可被毒蕈碱类药物取代。氯氮平和硫利达嗪是两种独特的抗精神病药物,引起锥体外系副作用的可能性较低,它们均可取代QNB,而其他几种抗精神病药物则不能。除了这种明显的对胆碱能受体的直接竞争外,吗啡和苯丙胺通过对毒蕈碱受体的间接影响增加了QNB的结合。体内QNB结合不仅证实了体外研究结果,还检测到了毒蕈碱胆碱能受体动力学的间接变化,可能是经突触的变化。